» Articles » PMID: 28423647

Upregulation of the LncRNA Meg3 Induces Autophagy to Inhibit Tumorigenesis and Progression of Epithelial Ovarian Carcinoma by Regulating Activity of ATG3

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Apr 21
PMID 28423647
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Maternally expressed gene 3 (Meg3), a long non-coding RNA, has been reported to be associated with the pathogenesis of multiple malignancies. However, little is known regarding the role of Meg3 in epithelial ovarian cancer (EOC). In this study, we found that the expression of Meg3 was lower in epithelial ovarian carcinoma, and has potential to be considered as a biomarker for ovarian cancer. After transfecting the ovarian cancer cell lines OVCAR3 and A2780 with Meg3, phenotypic changes and autophagy-related molecules were examined. Upregulation of Meg3 inhibited cell proliferation, plate colony formation, induced cell cycle arrest in G2 phases, and promoted apoptosis. Observation of autophagosomes was performed by transmission electron microscopy. The expression levels of LC3-II, ATG3, LAMP1 were elevated, while SQSTM1/p62 expression declined. Upregulated expression of Meg3 also suppressed tumorigenesis in vivo in a xenograft mouse model through upregulating ATG3 expression. RIP (ribonucleoprotein immunoprecipitation) and RNA pull-down assays showed that Meg3 was co-immunoprecipitated with ATG3. In addition, Meg3 protected ATG3 mRNA from degradation following treatment with actinomycin D. Overall, our results suggest that the lncRNA Meg3 acts as a tumor suppressor in EOC by regulating ATG3 activity and inducing autophagy.

Citing Articles

Regulating the regulators: long non-coding RNAs as autophagic controllers in chronic disease management.

Kumar A, Yap K, BharathwajChetty B, Lyu J, Hegde M, Abbas M J Biomed Sci. 2024; 31(1):105.

PMID: 39716252 PMC: 11667983. DOI: 10.1186/s12929-024-01092-9.


Noncoding RNAs: the crucial role of programmed cell death in osteoporosis.

Han J, Zhu Y, Zhang J, Kapilevich L, Zhang X Front Cell Dev Biol. 2024; 12:1409662.

PMID: 38799506 PMC: 11116712. DOI: 10.3389/fcell.2024.1409662.


The roles of long non-coding RNAs in ovarian cancer: from functions to therapeutic implications.

Hu Z, Yuan L, Yang X, Yi C, Lu J Front Oncol. 2024; 14:1332528.

PMID: 38725621 PMC: 11079149. DOI: 10.3389/fonc.2024.1332528.


Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response.

Peng B, Li J, Yan Y, Liu Y, Liang Q, Liu W Front Pharmacol. 2023; 14:1162045.

PMID: 37063265 PMC: 10102359. DOI: 10.3389/fphar.2023.1162045.


Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics.

Kumar A, Girisa S, AlQahtani M, Abbas M, Hegde M, Sethi G Cells. 2023; 12(5).

PMID: 36899946 PMC: 10000689. DOI: 10.3390/cells12050810.


References
1.
Zhang X, Zhou Y, Mehta K, Danila D, Scolavino S, Johnson S . A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003; 88(11):5119-26. DOI: 10.1210/jc.2003-030222. View

2.
Shimizu S, Konishi A, Nishida Y, Mizuta T, Nishina H, Yamamoto A . Involvement of JNK in the regulation of autophagic cell death. Oncogene. 2010; 29(14):2070-82. DOI: 10.1038/onc.2009.487. View

3.
Bruney L, Liu Y, Grisoli A, Ravosa M, Stack M . Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells. Oncotarget. 2016; 7(16):21968-81. PMC: 5008337. DOI: 10.18632/oncotarget.7880. View

4.
Green D, Llambi F . Cell Death Signaling. Cold Spring Harb Perspect Biol. 2015; 7(12). PMC: 4665079. DOI: 10.1101/cshperspect.a006080. View

5.
Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M . Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2010; 30(16):1956-62. PMC: 3230933. DOI: 10.1038/onc.2010.568. View